Kent Lake Capital LLC Delcath Systems, Inc. Transaction History

Kent Lake Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.59 - $3.71 $323,750 - $463,750	125,000 Added 132.32%	219,468 $790,000
Q2 2022 Aug 15, 2022	BUY	$3.62 - $6.55 $341,974 - $618,765	94,468 New	94,468 $377,000
Q1 2021 May 17, 2021	SELL	$12.42 - $23.81 $1.02 Million - $1.96 Million	-82,319 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.55 - $18.69 $868,465 - $1.54 Million	82,319 New	82,319 $1.48 Million

7.62M

198K

41.7K

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $83.9M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

Get notified when there are updates to the investment portfolio of Kent Lake Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Kent Lake Capital LLC with notifications on news.